Neurocarrus Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed
  • (In Progress)

  • Investors
  • 6

Neurocarrus General Information

Description

Developer of a novel drug delivery technology designed to safely disrupt pain signals without addiction-forming medications or disruption of muscular control. The company's technology is engineered for individuals experiencing pain as a result of tissue injury or inflammation as well as patients with acute nerve damage and fights against the prescription opioid abuse and heroin epidemic, enabling physicians to treat the physiological symptoms of pain without invasive surgical procedures or systemically absorbed drugs.

Contact Information

Website
www.neurocarrus.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 60 Via Buena Vista
  • Monterey, CA 93940
  • United States
+1 (402)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 60 Via Buena Vista
  • Monterey, CA 93940
  • United States
+1 (402)

Neurocarrus Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurocarrus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Seed Round In Progress Pre-Clinical Trials
12. Equity Crowdfunding 11-Jun-2024 Announced Pre-Clinical Trials
11. Grant 17-Nov-2023 Completed Pre-Clinical Trials
10. Grant 18-Sep-2023 Completed Pre-Clinical Trials
9. Secondary Transaction - Private 24-May-2022 Completed Startup
8. Later Stage VC Completed Startup
7. Grant 01-Oct-2020 Completed Startup
6. Grant 30-Sep-2020 Completed Startup
5. Equity Crowdfunding 18-Apr-2019 $344K $544K Completed Startup
4. Grant 01-Jul-2018 $100K $200K Completed Startup
To view Neurocarrus’s complete valuation and funding history, request access »

Neurocarrus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel drug delivery technology designed to safely disrupt pain signals without addiction-forming medicati
Drug Discovery
Monterey, CA
3 As of 2024

Tampa, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neurocarrus Competitors (1)

One of Neurocarrus’s competitors is Pacira BioSciences, a Formerly VC-backed company based in Tampa, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pacira BioSciences Formerly VC-backed Tampa, FL
You’re viewing 1 of 1 competitors. Get the full list »

Neurocarrus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurocarrus Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
National Institutes of Neurological Disorders and Stroke Government
SOSV Venture Capital Minority
National Institute on Drug Abuse (NIDA) Government
The Nebraska Department of Economic Development Government
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Neurocarrus FAQs

  • When was Neurocarrus founded?

    Neurocarrus was founded in 2015.

  • Where is Neurocarrus headquartered?

    Neurocarrus is headquartered in Monterey, CA.

  • What is the size of Neurocarrus?

    Neurocarrus has 3 total employees.

  • What industry is Neurocarrus in?

    Neurocarrus’s primary industry is Drug Discovery.

  • Is Neurocarrus a private or public company?

    Neurocarrus is a Private company.

  • What is Neurocarrus’s current revenue?

    The current revenue for Neurocarrus is .

  • How much funding has Neurocarrus raised over time?

    Neurocarrus has raised $685K.

  • Who are Neurocarrus’s investors?

    National Institutes of Health, National Institutes of Neurological Disorders and Stroke, SOSV, National Institute on Drug Abuse (NIDA), and The Nebraska Department of Economic Development are 5 of 6 investors who have invested in Neurocarrus.

  • Who are Neurocarrus’s competitors?

    Pacira BioSciences is a competitor of Neurocarrus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »